奥科达 获得首个产品批准并以Vigadrone™品牌推出氨己烯酸口服溶液用粉剂
July 16, 2018 08:00 ET
|
Aucta Pharmaceuticals, Inc.
新不伦瑞克省、新泽西州, July 16, 2018 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. （奥科达） 于今日宣布其递交的简略 新药申请获得美国食品药品监督管理局最终批准后，公司已经开始运输500 mg氨己烯酸口服溶液用粉剂产品。奥科达的商业合作伙伴 Upsher-Smith Laboratories, LLC...
Aucta Receives its First Product Approval and Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone™
July 16, 2018 08:00 ET
|
Aucta Pharmaceuticals, Inc.
NEW BRUNSWICK, N.J., July 16, 2018 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) announced today that it has begun shipping Vigabatrin for Oral Solution, USP, 500 mg, following final...